Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23200102 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed First-in-Human Study With GNbAC1 in Healthy Volunteers
Condition: Multiple Sclerosis
Interventions: Biological: GNbAC1;   Biological: GNbAC1 placebo

Indicates status has not been verified in more than two years